SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bill Wexler who wrote (4800)7/12/1998 3:04:00 AM
From: Brander  Read Replies (1) of 7041
 
No Bill, many of your statements were distortions of the truth. Just because Novastan was turned down by the FDA does not mean that all your statements you made about TXB were accurate. They weren't. To say that because Novastan was turned down by the FDA you were 100% correct is a fallacy in logic. Regardless of how ZONA turns out, your statements have not been 100% correct, as you state. The current discussion is about the clinical trials, which you said revealed absolutely no evidence that the drug tested (Vasomax) was effective for the treatment of ED. As I remember the results, there was a statistical difference in favor of Zonagen being more effective than placebo. If you can prove otherwise, I encourage you to do so. The other point was the patent, which you said they would never get. The most recent patent seemed fairly protective for a rapid absorbing form of phentolamine. Again, if you can provide evidence that I am incorrect, please do so.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News